Ameridose Recalls Products After FDA Investigation

Pain Management

A second Massachusetts compounding pharmacy, Ameridose, has recalled products in the wake of a meningitis outbreak linked to the New England Compounding Center pharmacy, according to a WebMD report. No cases of meningitis have been linked to Ameridose and an FDA investigation of the company hasn't found evidence to suggest contamination. However, the FDA did ask Ameridose to improve its sterility process, and the company will post recalled products on its website.

More Articles on Pain Management:

Early Physical Therapy for Low Back Pain Saves Healthcare Dollars

Dr. Vladimir Redko Joins North American Spine

Washington Center for Pain Management to Expand

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Most Read - Pain Management

Featured Webinars

Featured Whitepapers